Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103788 · ClinicalTrials.gov registry record · NA
Evaluation of Increased Absorption of a Curcumin Emulsion (CurQ+) in Healthy Volunteers
A NA study, sponsored by ESM Technologies.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04103788 is a NA study that has completed, run by ESM Technologies. The registered enrollment target is 10 participants.
The verdict
NCT04103788, a NA study, has completed, sponsored by ESM Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is intended to evaluate the comparative effects of direct analysis of serum samples versus pre-treatment with enzymatic hydrolysis in split samples obtained from dosing with a highly absorbed curcumin emulsion product that is commercially available as BIOCURC.
Interventions
- DIETARY_SUPPLEMENT 95% Curcuminoid Powder
- DIETARY_SUPPLEMENT CurQ+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04103788
The ClinicalTrials.gov registry entry for NCT04103788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ESM Technologies, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 95% Curcuminoid Powder is the first listed.
NCT04103788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04103788 about?
NCT04103788 is a clinical study titled "Evaluation of Increased Absorption of a Curcumin Emulsion (CurQ+) in Healthy Volunteers". This study is intended to evaluate the comparative effects of direct analysis of serum samples versus pre-treatment with enzymatic hydrolysis in split samples obtained from dosing with a highly absorbed curcumin emulsion product that is commercially available as BIOCURC.
What is the current status of trial NCT04103788?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-03-27. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT04103788?
The interventions under investigation include: 95% Curcuminoid Powder (DIETARY_SUPPLEMENT), CurQ+ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04103788?
This trial is sponsored by ESM Technologies, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.